Sealonix
Sealonix, Inc. is a privately held company based in Bedford, MA, focused on developing and commercializing hemostatic sealants using proprietary biomaterials. Founded in January 2023 by serial entrepreneur Dr. Amar Sawhney, the company aims to address the unmet needs in surgical bleeding control with innovative, proven technology. Their initial product is a sealant patch designed for rapid hemostasis in abdominopelvic procedures, leveraging biomaterials successfully used in various medical applications for over 10 million patients. Sealonix is committed to advancing surgical outcomes and reducing complications associated with bleeding.
Industries
Nr. of Employees
small (1-50)
Products
Investigational sealant patch (investigational device)
A patch-form surgical sealant intended to provide rapid hemostasis during abdominopelvic procedures and to be used when suturing is not feasible or adequate.
Investigational sealant patch (investigational device)
A patch-form surgical sealant intended to provide rapid hemostasis during abdominopelvic procedures and to be used when suturing is not feasible or adequate.
Services
Sponsorship and conduct of investigational device clinical studies
Sponsor-led clinical studies comparing an investigational surgical sealant patch to a comparator hemostat, including study design, patient enrollment coordination, and coverage of study-specific testing costs.
Sponsorship and conduct of investigational device clinical studies
Sponsor-led clinical studies comparing an investigational surgical sealant patch to a comparator hemostat, including study design, patient enrollment coordination, and coverage of study-specific testing costs.
Expertise Areas
- Hemostatic sealant development
- Biomaterials and hydrogel platforms
- Medical device development and commercialization
- Clinical trial management for investigational devices
Key Technologies
- Hemostatic biomaterials
- Hydrogel-based device platforms
- Surgical sealant patches
- Randomized comparative clinical trial design